Descrizione business
Werewolf Therapeutics is a highly innovative company striving to redefine the cancer treatment landscape with potential best-in-class therapies. It develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. They invented proprietary PREDATOR™ protein engineering technology to design and engineer the future of immuno-oncology biotherapeutics for patients.
Consiglio di amministrazione & Consiglio di sorveglianza
CEO |
Dan Hicklin |
Consiglio di amministrazione |
Tim Trost, Randi Isaacs, Chulani Karunatilake, Ellen Lubman, Cynthia Seidel-Dugan |
Consiglio di sorveglianza |
Luke Evnin, Michael Atkins, Meeta Chatterjee, Derek DiRocco, Dan Hicklin, Alon Lazarus, Briggs W. Morrison, Mike Sherman |
Dati aziendali
Name: |
Werewolf Therapeutics Inc |
Indirizzo: |
200 Talcott Avenue, 2nd Floor,Watertown, MA 02472 |
Telefono: |
+1 617-952-0555 |
Fax: |
- |
E-mail: |
info@werewolftx.com
|
Internet: |
https://werewolftx.com/ |
Industria: |
Biotechnology |
Settore: |
Biotechnology |
Sub settore: |
- |
Fine dell'anno finanziario: |
31/12 |
Flottante libero: |
- |
Data dell'IPO: |
29/04/2021 |
Rapporti con gli investitori
Name: |
Josh Rappaport |
IR telefono: |
+1 212-362-1200 |
IR Fax: |
- |
IR e-mail: |
IR@werewolftx.com
|